The Priority of Non-HDL-C Assessment to Predict New Lesions among Stable Angina Patients with Strong Statins - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34039817/
Non-HDL-C ≥ 100 mg/dL was determined to be the independent risk factor for the occurrence of new lesions 9 months and ≤ 2 years after PCI among stable angina patients...
Inclisiran for treating primary hypercholesterolaemia or mixed dyslipidaemia
Source : https://www.nice.org.uk/guidance/ta733/documents/html-content-2
The Appraisal Committee has prepared a Final Appraisal Document (FAD) on Inclisiran for treating primary hypercholesterolaemia or mixed dyslipidaemia and submitted it to NICE. The FAD has been sent to...
Association of circulating oxidized LDL-C/LDL-C ratio with severity of coronary atherosclerosis and other emerging biomarkers of cardiovascular disease in patients with type 2 diabetes
Source : https://europepmc.org/article/ppr/ppr406901
Background: Atherosclerosis cardiovascular diseases (ASCVD) are the leading cause of mortality and morbidity in patients with diabetes. But there are still no simpler and more effective biomarkers which can predict...
New players in the treatment of hypercholesterolaemia: focus on bempedoic acid and inclisiran - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34650356/
Dyslipidaemias and in particular elevated plasma low-density lipoprotein cholesterol (LDL-C) levels are major risk factors for atherosclerotic cardiovascular disease (ASCVD). Indeed, the more LDL-C is reduced the larger will be...